ArticleBMC microbiology2026
Fosfomycin at sub-minimum inhibitory concentration impairs biofilm and efflux pump activity in multidrug-resistant Klebsiella pneumoniae isolates.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKlebsiella pneumoniae plays a critical role in hospital-acquired infections, which pose a serious threat globally. Older antibiotics such as fosfomycin are being reconsidered to combat MDR K. pneumoniae. In healthcare settings, bacteria are exposed frequently to antibiotics at sub-inhibitory concentrations (sub-MICs), which may alter their virulent characteristics. The aim of this research was to investigate the impact of fosfomycin at sub-MICs on the virulence determinants of MDR K. pneumoniae.
methodsThe effect of sub-MIC fosfomycin treatment on biofilm formation was evaluated by crystal violet assay and confocal laser scanning microscopy (CLSM). The cartwheel technique was employed to study efflux pump activity phenotypically. The expression of genes of biofilm (fimH, mrkD) and efflux pump (acrA, acrB) was determined using reverse transcription quantitative PCR (RT-qPCR). Scanning electron microscopy (SEM) was also utilized to visualize the morphological changes.
resultsThe MIC of fosfomycin against K. pneumoniae MDR isolates ranged from 256 to 1024 µg/mL. The biofilm formation ability of isolates (n = 50) was reduced significantly (P < 0.05) following the exposure to ¼ MIC of fosfomycin. CLSM analysis revealed disruption of biofilm structure, reduced thickness and density, and increased percentages of dead cells. RT-qPCR revealed 20-60% downregulation of fimH and mrkD and downexpression of acrA and acrB. SEM analysis showed pronounced morphological changes, including a characteristic cauliflower-like deformation.
conclusionFosfomycin at sub-inhibitory levels is able to disrupt biofilm architecture and the efflux pump activity in MDR K. pneumoniae, pointing to its possible role as an adjunct agent in combating antibiotic resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.